Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension

Figure 11

Drug release kinetics of Nateglinide (sustain release) layer in bilayer tablet.

(a)

(b)

(c)

(d)